Linardakis E - Search Results

1

Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.

Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Linardakis E, et al. Cancer Res. 2002 Oct 1;62(19):5495-504. Cancer Res. 2002. PMID: 12359759

2

Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.

Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ, Linardakis E, Riddle D, Dietz A, Lohse CM, Strome S, Peterson T, Simari R, Vile RG. Bateman AR, et al. Among authors: linardakis e. Cancer Res. 2002 Nov 15;62(22):6566-78. Cancer Res. 2002. PMID: 12438252

3

Macrophages orchestrate the immune response to tumor cell death.

Gough MJ, Melcher AA, Ahmed A, Crittenden MR, Riddle DS, Linardakis E, Ruchatz AN, Emiliusen LM, Vile RG. Gough MJ, et al. Among authors: linardakis e. Cancer Res. 2001 Oct 1;61(19):7240-7. Cancer Res. 2001. PMID: 11585761

4

Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.

Todryk S, Melcher AA, Hardwick N, Linardakis E, Bateman A, Colombo MP, Stoppacciaro A, Vile RG. Todryk S, et al. Among authors: linardakis e. J Immunol. 1999 Aug 1;163(3):1398-408. J Immunol. 1999. PMID: 10415040

5

Transcriptional control: an essential component of cancer gene therapy strategies?

Harrington KJ, Linardakis E, Vile RG. Harrington KJ, et al. Among authors: linardakis e. Adv Drug Deliv Rev. 2000 Nov 15;44(2-3):167-84. doi: 10.1016/s0169-409x(00)00093-4. Adv Drug Deliv Rev. 2000. PMID: 11072113 Review.

6

Prevalence of attention deficit hyperactivity disorder in schoolchildren in Athens, Greece. Association of ADHD subtypes with social and academic impairment.

Skounti M, Giannoukas S, Dimitriou E, Nikolopoulou S, Linardakis E, Philalithis A. Skounti M, et al. Among authors: linardakis e. Atten Defic Hyperact Disord. 2010 Nov;2(3):127-32. doi: 10.1007/s12402-010-0029-8. Epub 2010 Jun 29. Atten Defic Hyperact Disord. 2010. PMID: 21432598

7

Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases.

Dimitriou H, Linardakis E, Martimianaki G, Stiakaki E, Perdikogianni CH, Charbord P, Kalmanti M. Dimitriou H, et al. Among authors: linardakis e. Cytotherapy. 2008;10(2):125-33. doi: 10.1080/14653240701851332. Cytotherapy. 2008. PMID: 18368591

8

Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia.

Spanaki A, Linardakis E, Perdikogianni C, Stiakaki E, Morotti A, Cilloni D, Kalmanti M. Spanaki A, et al. Among authors: linardakis e. Leuk Res. 2007 Apr;31(4):570-2. doi: 10.1016/j.leukres.2006.03.030. Epub 2006 Jul 31. Leuk Res. 2007. PMID: 16876863

9

Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia.

Spanaki A, Perdikogianni C, Linardakis E, Kalmanti M. Spanaki A, et al. Among authors: linardakis e. Leuk Res. 2007 May;31(5):639-42. doi: 10.1016/j.leukres.2006.06.006. Epub 2006 Jul 24. Leuk Res. 2007. PMID: 16860864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters